Artificially low mild cognitive impairment to normal reversion rate in the Alzheimer's Disease Neuroimaging Initiative

Introduction We examined reasons for low mild cognitive impairment (MCI)‐to‐cognitively normal (CN) reversion rates in the Alzheimer's Disease Neuroimaging Initiative (ADNI). Methods CN and MCI participants were identified as remaining stable, progressing, or reverting at 1‐year of follow‐up (Year 1). Application of ADNI's MCI criteria at Year 1 in addition to Alzheimer's disease biomarkers by group were examined. Results The MCI‐to‐CN reversion...